Abstract:Backgrounds The impaired function of endogenous bone marrow mesenchymal stem cells (BMSCs) is a determinant in the development of osteoporosis (OP). BMSCs have been described the potential relevance of autophagy to the pathogenesis of OP. However, the underlying mechanism remains unclear. Our previous researches have found leucine‐rich repeat‐containing 17 (LRRc17) secreted by MSCs, a member of the LRR superfamily, was markedly enriched in the age‐related pathways. This study aims to investigate the effects of LRRc17 in aging process of MSCs. Methods Hydrogen peroxide (H 2 O 2 ) induced aging MSCs and natural senescent cell cultivated from old and young C57BL/6 mice were used to evaluate the effects of LRRc17 on MSCs. Western blot, flow cytometry was used to detect autophagy, apoptosis and cell cycle respectively. Furthermore, mitochondrial function was measured by Mitosox, JC‐1, ATP. The mitochondrial morphology was detected by Mitotracker. Moreover, co‐culture was performed to detect the effects of LRRc17 secreted by MSCs on osteoblast (OB) and osteoclast (OC). Results MSCs exhibited a senescent phenotype after treatment with hydrogen peroxide. This result was improved after the addition of rapamycin. Interestingly, compared with the H 2 O 2 ‐treated group, MSCs transfected with shLRRc17 showed increased DNA synthesis phase, and decreased apoptosis ratio, ROS (Fig. 1A, B, C ). Autophagy related protein LC3 II, Beclin1 were up‐upregulated and P62 was down‐regulated (Fig. 1G ). And mitochondrial morphology was also significantly improved (Fig. 1D, E ). More importantly, LRRc17 reversed the loss of Ψm (Fig. 2A ) and enhanced ATP content (Fig. 1F ). Co‐culture showed that silenced LRRc17 in MSCs enhanced the osteogenic ability of OB and decreased the bone resorption capacity of OC, and the opposite result was obtained after overexpression (Fig. 2B ). Conclusions LRRc17 enhances characterizations of BMSCs through attenuating MSC senescence during OP, and which could lead to novel therapies to target altered bone formation. Support or Funding Information This work was supported by the Chengdu Giant Panda Breeding Research Foundation (2016cdspt001). Figure 1 Figure 2

LncRNA ORLNC1 Promotes Bone Marrow Mesenchyml Stem Cell Pyroptosis Induced by Advanced Glycation End Production by Targeting miR-200b-3p/Foxo3 Pathway

The Long Non-coding RNA-ORLNC1 Regulates Bone Mass by Directing Mesenchymal Stem Cell Fate

LncRNA GHET1 from bone mesenchymal stem cell–derived exosomes improves doxorubicin-induced pyroptosis of cardiomyocytes by mediating NLRP3

LncRNA AC003090.1 Mediates miR-203a-3p/FOXP1 Axis to Promote the Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells

LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer

lncRNA MALAT1 mediates osteogenic differentiation of bone mesenchymal stem cells by sponging miR-129-5p

Long Noncoding RNA MALAT1 Promotes High Glucose-Induced Human Endothelial Cells Pyroptosis by Affecting NLRP3 Expression Through Competitively Binding Mir-22.

Down-regulation of LRRc17 secreted by BMSCs alleviates age-related bone aging through autophagy enchancement

Long Non-coding RNAs LOC100126784 and POM121L9P Derived from Bone Marrow Mesenchymal Stem Cells Enhance Osteogenic Differentiation Via the Mir-503-5p/sorbs1 Axis.

Long Non-Coding RNA PGM5-AS1 Modulates Epithelial-Mesenchymal Transition and Invasion and Metastasis of Osteosarcoma Cells by Impairing Mir-140-5p-mediated FBN1 Inhibition

MicroRNA-139-3p regulates osteoblast differentiation and apoptosis by targeting ELK1 and interacting with long noncoding RNA ODSM

Retracted: Long Non‐coding RNA PGM5‐AS1 Promotes Epithelial‐mesenchymal Transition, Invasion and Metastasis of Osteosarcoma Cells by Impairing Mir‐140‐5p‐mediated FBN1 Inhibition

LncRNA-OG Promotes the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells under the Regulation of Hnrnpk

LncRNA ENST00000563492 promoting the osteogenesis–angiogenesis coupling process in bone mesenchymal stem cells (BMSCs) by functions as a ceRNA for miR-205-5p

Overexpression of lncRNA LINC00665 inhibits the proliferation and chondroblast differentiation of bone marrow mesenchymal stem cells by targeting miR-214-3p

LINC00963 Represses Osteogenic Differentiation of hBMSCs via the miR-10b-5p/RAP2A/AKT Axis

LncRNA AK077216 promotes RANKL‐induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45

LncRNA KCNQ1OT1 promotes osteogenic differentiation via miR-205-5p/RICTOR axis

Long non-coding RNA taurine upregulated gene 1 is downregulated in osteoporosis and influences the osteogenic differentiation of bone marrow mesenchymal stem cells

METTL3-mediated LINC00657 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells Via Mir-144-3p/bmpr1b Axis

&Lt;p>lncrna <em>snhg16</em> Regulates the Progress of Acute Myeloid Leukemia Through Mir183-5P–foxo1 Axis</p>